Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

119.19
Delayed Data
As of 4:00pm ET
 +3.26 / +2.81%
Today’s Change
96.63
Today|||52-Week Range
177.93
+9.70%
Year-to-Date
Intercept (ICPT) Q4 Loss Wider than Expected, Revenues Beat
4:28pm / Zacks.com - Paid Partner Content
Intercept (ICPT) to Post Q4 Earnings: What's in the Cards?
Feb 21 / Zacks.com - Paid Partner Content
Intercept (ICPT) Reports a Wider Q4 Loss
Feb 23 / Zacks.com - Paid Partner Content
Investors Are Betting Big Against Intercept Pharmaceuticals. Are They Wrong?
Feb 17 / MotleyFool.com - Paid Partner Content
Drug Stocks Q4 Earnings Slated for Feb 23: BMRN, ICPT & More
Feb 22 / Zacks.com - Paid Partner Content
Why Intercept Pharmaceuticals' Latest News Caused the Stock to Jump
Feb 11 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close115.93
Today’s open115.68
Day’s range114.70 - 119.74
Volume561,187
Average volume (3 months)520,005
Market cap$2.9B
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+29.86%
Earnings growth (this year)-63.41%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+59.74%
P/E ratioNM
Price/Sales1,272.01
Price/Book4.70

Competitors

 Today’s
change
Today’s
% change
ENDPEndo International P...-0.24-1.79%
HZNPHorizon Pharma PLC+0.30+1.75%
CBPOChina Biologic Produ...-1.05-0.95%
PBHPrestige Brands Hold...-0.18-0.31%
Data as of 4:04pm ET, 02/24/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$3.75
Annual revenue (last year)$2.8M
Annual profit (last year)-$226.4M
Net profit margin-8,139.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Operating Officer
Jerome B. Durso
Corporate headquarters
New York, New York

Forecasts


Search for Jobs